| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/28/2006 | WO2006101603A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | WO2006101062A1 Process for producing carbapenem derivative having 1-alkylpyrrolidine structure |
| 09/28/2006 | WO2006100875A1 Pharmaceutical composition |
| 09/28/2006 | WO2006100710A1 Preventive or therapeutic composition for severe acute respiratory syndrome |
| 09/28/2006 | WO2006100552A1 Processes for the preparation of lopinavir and its intermediate - (s)-tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2h)-pyrimidineacetic acid |
| 09/28/2006 | WO2006100310A1 Heterobicylic inhibitors of hcv |
| 09/28/2006 | WO2006100106A1 3-carboxy pyrroles as anti-viral agents |
| 09/28/2006 | WO2006099978A1 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
| 09/28/2006 | WO2006099884A1 Beta-aminoalcohol antibiotics |
| 09/28/2006 | WO2006099789A1 A pharmaceutical preparation |
| 09/28/2006 | WO2006099721A1 Mhc class ii as a preventive vaccine against hiv infection |
| 09/28/2006 | WO2006078975A3 Improved vaccine against feline calicivirus |
| 09/28/2006 | WO2006067330B1 Pharmaceutical compositions based on fluorinated sulphamides and sulphinimides |
| 09/28/2006 | WO2006024120A3 Topical phytotherapeutic compound for the treatment of herpes based on uncaria tomentosa and extraction process for obtaining a vegetal extract from uncaria tomentosa |
| 09/28/2006 | WO2006003492A3 Compositions and methods for treating pathological infections |
| 09/28/2006 | WO2005072292A3 Methods for enhancing radiation therapy |
| 09/28/2006 | WO2005064008A9 Method and compositions for identifying anti-hiv therapeutic compounds |
| 09/28/2006 | WO2005021776A3 METHODS OF USING MAMMALIAN RNase H AND COMPOSITIONS THEREOF |
| 09/28/2006 | WO2004089305A3 Heparin/heparosan synthase from p.multocida, soluble and single action catalysts thereof and methods of making and using same |
| 09/28/2006 | WO2002008267A9 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 09/28/2006 | US20060218665 Anti-microbial peptide known as halocyntin, gene coding for said peptide, vector, transformed organism and composition containing said peptide |
| 09/28/2006 | US20060217561 Synthesis of substituted thiazoline carboxylic acids |
| 09/28/2006 | US20060217553 chemical preparation of diketopiperizine derivatives; useful as anticarcinogenic and antifungal agent |
| 09/28/2006 | US20060217551 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 09/28/2006 | US20060217531 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
| 09/28/2006 | US20060217530 Active against C5a receptors on polymorphonuclear leukocytes and macrophages; peptidomimetics; for treatment of inflammation |
| 09/28/2006 | US20060217439 Compounds with stabilized S-nitrosyl group and a free alcohol or a free thiol; nitric oxide (NO) releasing; bacteristats; reacting a polythiol or a thioalcohol with a nitrosylating agent (S-Nitrosyl-N-acetyl-D,L-penicillamine (SNAP) and and tert-butylnitrite); |
| 09/28/2006 | US20060217434 1-((4,14-(Dioxo),5-(1-hydroxy,1,2-dicarboxyethyl)),3-azaoctadec-6-enyl-),4-(phenoxy)benzene derivatives and salts ; extremely potent replication inhibitory activity against the hepatitis C virus (HCV); chronic hepatitis, cirrhosis and liver cancer; mild cytotoxicity in vitro; prophylaxis; prodrugs |
| 09/28/2006 | US20060217432 3,6-Disubstituted azabicyclo [3.1.0] hexane derivatives as muscarinic receptor antagonists |
| 09/28/2006 | US20060217413 4-Oxoquinoline compound and use thereof as HIV integrase inhibitor |
| 09/28/2006 | US20060217407 Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use Therefor |
| 09/28/2006 | US20060217406 7-(3-Pyridyl)-1,7-diazaspiro-[4,4]nonane and its salts and proline amides; capable of affecting nicotinic cholinergic receptors, e.g., as modulators of specific nicotinic receptor subtypes; neuroprotective agents |
| 09/28/2006 | US20060217402 Biocidal compounds and their preparation |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | US20060217361 Bicyclic 6-alkylidene-penems as beta-lactamase inhibitors |
| 09/28/2006 | US20060217345 Beta-L-nucleosides and use thereof as pharmaceutical agents for the treatment of viral diseases |
| 09/28/2006 | US20060217326 Group of nucleic acid fragments for prevention of hiv infection or aids and the usage thereof |
| 09/28/2006 | US20060217320 Soft gel formulations for saquinavir |
| 09/28/2006 | US20060217299 Degradation inhibitor for hepatitis b virus x interacting protein |
| 09/28/2006 | US20060216788 CASH (CASPASE HOMOLOGUE) with death effector domain, modulators of the function of FAS |
| 09/28/2006 | US20060216317 Delivery of polynucleotide agents to the central nervous system |
| 09/28/2006 | US20060216309 Identification of genes |
| 09/28/2006 | US20060216308 Genomic sequence that encode ptorprotein; drug for prevention, therapy of infections; induce immunology response |
| 09/28/2006 | US20060216307 Vaccine composition |
| 09/28/2006 | US20060216304 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same |
| 09/28/2006 | US20060216300 Recombinant antibodies and compositions and methods for making and using the same |
| 09/28/2006 | US20060216244 Delivery of compounds for the treatment of parkinson's through an inhalation route |
| 09/28/2006 | US20060216243 Delivery of Beta-Blockers Through An Inhalation Route |
| 09/28/2006 | CA2602355A1 Polyene antibiotics, compositions containing said antibiotics, method and micro-organisms used to obtain same and applications thereof |
| 09/28/2006 | CA2602294A1 Heterobicylic inhibitors of hvc |
| 09/28/2006 | CA2602140A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 09/28/2006 | CA2602097A1 Process for producing carbapenem derivatives having 1-alkylpyrrolidine structure |
| 09/28/2006 | CA2600759A1 1,2,4-triazole-5-one compounds as heterocyclic reverse transcriptase inhibitors |
| 09/28/2006 | CA2600533A1 Pharmaceutical composition |
| 09/27/2006 | EP1705182A1 Antitumoral and antiviral peptides |
| 09/27/2006 | EP1704869A1 VR-2332 viral nucleotide sequence and methods of use |
| 09/27/2006 | EP1704868A1 HLA binding peptides and their uses |
| 09/27/2006 | EP1704855A2 2-Cyclopenten-1-one and its Derivatives as Inhibitors of the NF-kappa B Factor |
| 09/27/2006 | EP1704142A1 Protease inhibitors |
| 09/27/2006 | EP1703919A1 Vaginal compositions for treating infections |
| 09/27/2006 | EP1703901A2 Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol |
| 09/27/2006 | EP1534687B1 2-phenylamino-4-trifluoromethyl-5-(benzyl- or pyridin-4-ylmethyl)carbamoylpyrimidine derivatives as selective cb2 cannabinoid receptor modulators |
| 09/27/2006 | EP1486208B1 Use of a novel preventive for infections |
| 09/27/2006 | EP1303537B1 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 09/27/2006 | EP1268759B1 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 09/27/2006 | EP1196433B1 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN ALPHA v BETA 6 |
| 09/27/2006 | CN1839152A Modified i bordetella /i adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof |
| 09/27/2006 | CN1839150A Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 09/27/2006 | CN1838963A A pharmaceutical ayurvedic preparation for treatment of aids |
| 09/27/2006 | CN1838947A Glycyrrhizin or derivatives thereof for treating or preventing severe acute respiratory syndrome (SARS) |
| 09/27/2006 | CN1838946A Pharmaceutical formulations of amyloid inhibiting compounds |
| 09/27/2006 | CN1837367A SiRNA sequence directing towards influenza B virus membrane protein gene and its application |
| 09/27/2006 | CN1837366A SiRNA sequence directing towards influenza B virus polymerase gene and its application |
| 09/27/2006 | CN1837365A SiRNA sequence directing towards influenza B virus nucleocapsid gene and its application |
| 09/27/2006 | CN1837229A Clarithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837225A Azithromycin derivatives and its preparation process and pharmaceutical application |
| 09/27/2006 | CN1837218A N2,N4-disubstituted pyrazolo [4.5-e][1,2,4] thiadiazine derivatives and use thereof |
| 09/27/2006 | CN1837215A N1,N3-disubstituted thieno[3,2-e][2,1,3] thiadiazine-2,2,4-triones derivatives and use thereof |
| 09/27/2006 | CN1837213A Bilobalide A derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837212A Bilobalide B derivatives and pharmaceutical application thereof |
| 09/27/2006 | CN1837203A Chiral 4,4'-dimethoxy-5,6,5',6'-bis methylene dioxy -2,2'-phthalic acid derivatives and process for preparing same |
| 09/27/2006 | CN1836717A Quality controlling method for pulse restoring injection |
| 09/27/2006 | CN1836715A External use medicine for quickly treating herpes zoster |
| 09/27/2006 | CN1836696A Medicine for treating hepatitis B and its preparing process |
| 09/27/2006 | CN1836691A Use of traditional Chinese medicine blister buttercup in treating virus hepatitis |
| 09/27/2006 | CN1836674A Antler lucid ganoderma and its extract for preparing pharmaceutical and food for treating cancer and immunity effect |
| 09/27/2006 | CN1836662A Prulifloxacin compound preparation |
| 09/27/2006 | CN1836660A Azlocillin/clavulanic acid antibacterial composition |
| 09/27/2006 | CN1836659A Azlocillin/sulbactam antibacterial composition |
| 09/27/2006 | CN1836658A Azlocillin/tazobactam antibacterial composition |
| 09/27/2006 | CN1836511A Synergistic microbicidal combination |
| 09/27/2006 | CN1836510A Synergistic microbicidal combination |
| 09/27/2006 | CN1276778C SARS nucleic acid vaccine and preparation method |
| 09/27/2006 | CN1276777C SARS vaccine of adenovirus vector and preparation method, application of coronavirus S gene |
| 09/26/2006 | US7112683 Cyclic sulfone containing retroviral protease inhibitors |
| 09/26/2006 | US7112672 Reacting a phosphoranylidene cephem compound with acetaldehyde in the presence of a base in a solvent mixture comprising diethyl ether |
| 09/26/2006 | US7112611 Antitumor, anticancer agents; respiratory system disorders; brain disorders |
| 09/26/2006 | US7112606 Heterocyclic arylsulfonamidobenzylic compounds |
| 09/26/2006 | US7112603 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |